US equities
|
MU
$1,035.84
▼-4.79%
NVDA
$230.48
▼-2.94%
SNDK
$1,609.46
▼-4.90%
AMD
$620.68
▼-3.90%
INTC
$107.08
▼-5.34%
AAPL
$340.42
▲+1.11%
META
$720.89
▼-0.06%
SPCX
$160.57
▼-4.19%
MU
$1,035.84
▼-4.79%
NVDA
$230.48
▼-2.94%
SNDK
$1,609.46
▼-4.90%
AMD
$620.68
▼-3.90%
INTC
$107.08
▼-5.34%
AAPL
$340.42
▲+1.11%
META
$720.89
▼-0.06%
SPCX
$160.57
▼-4.19%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Astrana Health Inc. - Common Stock
(NQ:
ASTH
)
35.87
-1.27 (-3.42%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Astrana Health Inc. - Common Stock
< Previous
1
2
3
4
5
Next >
Astrana Health (ASTH): Buy, Sell, or Hold Post Q2 Earnings?
October 08, 2026
Astrana Health’s 35.1% return over the past six months has outpaced the S&P 500 by 19.8%, and its stock price has climbed to $37.03 per share. This run-up mi...
Via
StockStory
Topics
Artificial Intelligence
Stocks
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
October 06, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Healthcare Technology for Providers Stocks Q2 In Review: Astrana Health (NASDAQ:ASTH) Vs Peers
September 29, 2026
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) ...
Via
StockStory
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc. - ASTH
September 29, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Astrana Health (NASDAQ:ASTH) Falls on Q2 Revenue Miss Despite Earnings Beat
↗
August 06, 2026
Via
Chartmill
Astrana Health (NASDAQ:ASTH) Screens as a Powerful Minervini Trend Template Stock with High Growth Momentum
↗
July 03, 2026
Via
Chartmill
ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law
September 28, 2026
From
Schall, Brown & Schwartz LLP
Via
Business Wire
Why Astrana Health (ASTH) Shares Are Trading Lower Today
September 23, 2026
What Happened? Shares of healthcare services company Astrana Health fell 5.5% in the afternoon session after the company disclosed a "material" cybersecurity...
Via
StockStory
Topics
Data Breach
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH
September 22, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Astrana Health, Inc. (NASDAQ: ASTH) for Potential Violations of the Federal Securities Laws
September 22, 2026
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Astrana Health, Clover Health, Alignment Healthcare, and Novavax Stocks Trade Down, What You Need To Know
September 15, 2026
What Happened? A number of stocks fell in the morning session after bipartisan lawmakers introduced the Protecting Approved Care Act, legislation aimed at re...
Via
StockStory
2 Cash-Producing Stocks with Competitive Advantages and 1 We Turn Down
September 15, 2026
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Via
StockStory
Topics
Energy
2 Stocks Under $50 on Our Watchlist and 1 That Underwhelm
August 14, 2026
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha...
Via
StockStory
Astrana Health (ASTH) Q2 2026 Earnings Call Transcript
↗
August 13, 2026
Revenue jumped 49% to $972.5 million as adjusted EPS hit record $0.80.
Via
The Motley Fool
Topics
Earnings
Retirement
5 Must-Read Analyst Questions From Astrana Health’s Q2 Earnings Call
August 13, 2026
Astrana Health’s second quarter was met with a positive market response, as management highlighted several drivers behind the results. The company saw contin...
Via
StockStory
Topics
Earnings
ASTH Q2 Deep Dive: AI-Driven Operating Leverage and Strategic Expansion Shape Outlook
August 07, 2026
Healthcare services company Astrana Health missed Wall Street’s revenue expectations in Q2 CY2026, but sales rose 48.5% year on year to $972.5 million. Next ...
Via
StockStory
Astrana Health Q2 Earnings Call Highlights
↗
August 06, 2026
Astrana Health (NASDAQ:ASTH) reported second-quarter 2026 revenue of $973 million, up 49% from a year earlier, while adjusted EBITDA increased 43% to $69 million. Adjusted diluted earnings per share...
Via
MarketBeat
Topics
Earnings
Astrana Health (NASDAQ:ASTH) Beats Q2 CY2026 Non-GAAP EPS Estimates, Stock Soars 5.1%
August 06, 2026
Healthcare services company Astrana Health fell short of the market’s revenue expectations in Q2 CY2026, but sales rose 48.5% year on year to $972.5 million....
Via
StockStory
Astrana Health (ASTH) Q2 Earnings: What To Expect
August 04, 2026
Healthcare services company Astrana Health will be reporting results this Thursday after market hours. Here’s what to look for. Astrana Health beat analysts’...
Via
StockStory
Topics
Artificial Intelligence
2 Reasons to Like ASTH and 1 to Stay Skeptical
July 15, 2026
The past six months have been a windfall for Astrana Health’s shareholders. The company’s stock price has jumped 79%, hitting $49.01 per share. This was part...
Via
StockStory
Topics
Artificial Intelligence
1 Profitable Stock to Target This Week and 2 We Question
July 10, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today does...
Via
StockStory
2 Healthcare Stocks for Long-Term Investors and 1 We Turn Down
June 30, 2026
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Shareholders who bet on the industry have been rewarded lately as...
Via
StockStory
2 Russell 2000 Stocks with Exciting Potential and 1 We Ignore
June 15, 2026
The Russell 2000 (^RUT) is home to many small-cap stocks, offering investors the chance to uncover hidden gems before the broader market catches on. However,...
Via
StockStory
Topics
Energy
2 Growth Stocks Set to Flourish and 1 Facing Headwinds
June 05, 2026
Growth is a hallmark of all great companies, but the laws of gravity eventually take hold. Those who rode the COVID boom and ensuing tech selloff in 2022 wil...
Via
StockStory
Topics
Electric Vehicles
A Look Back at Healthcare Technology for Providers Stocks’ Q1 Earnings: Astrana Health (NASDAQ:ASTH) Vs The Rest Of The Pack
May 25, 2026
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in...
Via
StockStory
Healthcare Technology for Providers Stocks Q1 Earnings: Omnicell (NASDAQ:OMCL) Best of the Bunch
May 21, 2026
As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the healthcare technology for providers in...
Via
StockStory
1 Cash-Producing Stock to Consider Right Now and 2 We Avoid
May 19, 2026
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns. Some cash-heavy businesses struggle with inefficient...
Via
StockStory
Topics
Artificial Intelligence
2 Mooning Stocks Worth Investigating and 1 We Question
May 15, 2026
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, pos...
Via
StockStory
Topics
Initial Public Offering
5 Revealing Analyst Questions From Astrana Health’s Q1 Earnings Call
May 14, 2026
Astrana Health’s first quarter was marked by progress in platform integration and the expansion of its AI-driven care model, leading to strong revenue growth...
Via
StockStory
Topics
Artificial Intelligence
Earnings
Astrana Health Says Prospect Deal Is Ahead of Schedule as Q1 Trends Beat Expectations
↗
May 12, 2026
Astrana Health (NASDAQ:ASTH) CEO and President Brandon Sim said the value-based care company is seeing early benefits from its acquisition of Prospect, while reporting stronger-than-expected...
Via
MarketBeat
Topics
Bankruptcy
< Previous
1
2
3
4
5
Next >
